TG Therapeutics Ownership 2024 | Who Owns TG Therapeutics Now?
Institutional Ownership
7.55%
Insider Ownership
9.59%
Retail Ownership
82.86%
Institutional Holders
95.00
TG Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 9.36% | 0.00% | 13,691,690 | 154,858 | 1.14% | 243,575,166 | Jun 30, 2024 |
| BLACKROCK INC. | 7.79% | 0.00% | 11,388,346 | 544,844 | 5.02% | 202,598,676 | Jun 30, 2024 |
| STATE STREET CORP | 4.58% | 0.01% | 6,696,143 | -1,100,436 | -14.11% | 119,124,384,000 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 2.49% | 5.72% | 3,645,562 | 477,106 | 15.06% | 64,854,548 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 2.22% | 0.07% | 3,243,481 | -83,733 | -2.52% | 57,701,527 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.19% | 0.01% | 3,206,390 | 98,946 | 3.18% | 57,052,520 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 1.96% | 1.52% | 2,870,131 | 2,870,131 | 100.00% | 51,059,630 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 1.56% | 9.27% | 2,280,000 | - | - | 40,561,200 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.43% | 0.01% | 2,084,708 | 798,280 | 62.05% | 37,086,954 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.42% | 0.00% | 2,081,888 | -119,562 | -5.43% | 37,036,788 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.40% | 0.05% | 2,051,762 | 2,051,762 | 100.00% | 36,500,846 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.27% | 1.72% | 1,861,277 | -123,685 | -6.23% | 33,112,118 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 1.16% | 0.01% | 1,688,651 | 135,161 | 8.70% | 30,041,101 | Jun 30, 2024 |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 1.08% | 0.58% | 1,572,929 | 98,892 | 6.71% | 27,982,407 | Jun 30, 2024 |
| MORGAN STANLEY | 1.02% | 0.00% | 1,488,742 | 317,005 | 27.05% | 26,484,728 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.00% | 0.01% | 1,457,908 | -2,026,138 | -58.15% | 25,936,183 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.97% | 0.24% | 1,419,534 | 14,937 | 1.06% | 25,253,510 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.96% | 1.88% | 1,400,000 | -225,000 | -13.85% | 24,906,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.93% | 0.06% | 1,361,128 | 1,097,250 | 415.82% | 24,214,467 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.87% | 0.00% | 1,276,317 | -24,071 | -1.85% | 22,705,680,000 | Jun 30, 2024 |
TG Therapeutics's largest institutional shareholder is VANGUARD GROUP INC, holding 9.36% of the company's total share outstanding, currently valued at $243.58M. The top 10 institutional shareholders own together 35.01% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | 1.56% | 9.27% | 2,280,000 | - | - | 40,561,200 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 2.49% | 5.72% | 3,645,562 | 477,106 | 15.06% | 64,854,548 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.17% | 3.90% | 251,600 | 21,300 | 9.25% | 4,475,964 | Jun 30, 2024 |
| M28 CAPITAL MANAGEMENT LP | 0.11% | 3.73% | 161,600 | - | - | 2,874,864 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.34% | 2.79% | 500,000 | -325,000 | -39.39% | 8,895,000 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.96% | 1.88% | 1,400,000 | -225,000 | -13.85% | 24,906,000 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.27% | 1.72% | 1,861,277 | -123,685 | -6.23% | 33,112,118 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 1.96% | 1.52% | 2,870,131 | 2,870,131 | 100.00% | 51,059,630 | Jun 30, 2024 |
| PARKWOOD LLC | 0.10% | 1.22% | 147,680 | 131,609 | 818.92% | 9,847,000 | Jun 30, 2024 |
| SPOTLIGHT ASSET GROUP, INC. | 0.06% | 1.02% | 82,100 | - | - | 1,460,559 | Jun 30, 2024 |
| QUANTUM PRIVATE WEALTH, LLC | 0.07% | 0.65% | 103,604 | - | - | 1,843,116 | Jun 30, 2024 |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 1.08% | 0.58% | 1,572,929 | 98,892 | 6.71% | 27,982,407 | Jun 30, 2024 |
| PARKMAN HEALTHCARE PARTNERS LLC | 0.12% | 0.43% | 180,320 | 25,281 | 16.31% | 3,207,893 | Jun 30, 2024 |
| JACKSON CREEK INVESTMENT ADVISORS LLC | 0.04% | 0.39% | 59,356 | -91 | -0.15% | 1,056,000 | Jun 30, 2024 |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 0.15% | 0.36% | 213,500 | 90,000 | 72.87% | 3,798,165 | Jun 30, 2024 |
| CAPITAL CS GROUP, LLC | 0.01% | 0.35% | 17,525 | - | - | 311,770 | Jun 30, 2024 |
| AVAII WEALTH MANAGEMENT, LLC | 0.02% | 0.30% | 30,233 | 342 | 1.14% | 537,848 | Jun 30, 2024 |
| CLARK FINANCIAL SERVICES GROUP INC /BD | 0.01% | 0.26% | 13,872 | -39 | -0.28% | 246,000 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.97% | 0.24% | 1,419,534 | 14,937 | 1.06% | 25,253,510 | Jun 30, 2024 |
| POINT72 EUROPE (LONDON) LLP | 0.11% | 0.24% | 160,769 | 160,769 | 100.00% | 2,860,077 | Jun 30, 2024 |
The largest TG Therapeutics shareholder by % of total assets is OPALEYE MANAGEMENT INC.. The company owns 2.28M shares of TG Therapeutics (TGTX), representing 9.27% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 1.96% | 1.52% | 2,870,131 | 2,870,131 | 100.00% | 51,059,630 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 1.40% | 0.05% | 2,051,762 | 2,051,762 | 100.00% | 36,500,846 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.93% | 0.06% | 1,361,128 | 1,097,250 | 415.82% | 24,214,467 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.55% | 0.03% | 802,003 | 802,003 | 100.00% | 14,267,633 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.43% | 0.01% | 2,084,708 | 798,280 | 62.05% | 37,086,954 | Jun 30, 2024 |
| NORGES BANK | 0.41% | 0.00% | 597,300 | 597,300 | 100.00% | 10,625,967 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.40% | 0.03% | 585,873 | 585,873 | 100.00% | 10,422,676 | Jun 30, 2024 |
| BLACKROCK INC. | 7.79% | 0.00% | 11,388,346 | 544,844 | 5.02% | 202,598,676 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.75% | 0.13% | 1,101,298 | 539,706 | 96.10% | 19,592,000 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.33% | 0.02% | 488,943 | 488,943 | 100.00% | 8,698,296 | Jun 30, 2024 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 2.49% | 5.72% | 3,645,562 | 477,106 | 15.06% | 64,854,548 | Jun 30, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | 0.27% | 0.02% | 389,123 | 355,710 | 1064.59% | 6,922,498 | Jun 30, 2024 |
| MORGAN STANLEY | 1.02% | 0.00% | 1,488,742 | 317,005 | 27.05% | 26,484,728 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.21% | 0.11% | 309,004 | 309,004 | 100.00% | 5,497,181 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.17% | 0.09% | 252,823 | 217,093 | 607.59% | 4,497,721 | Jun 30, 2024 |
| POINT72 EUROPE (LONDON) LLP | 0.11% | 0.24% | 160,769 | 160,769 | 100.00% | 2,860,077 | Jun 30, 2024 |
| UBS ASSET MANAGEMENT AMERICAS INC | 0.22% | 0.00% | 321,874 | 159,947 | 98.78% | 5,726,139 | Jun 30, 2024 |
| VANGUARD GROUP INC | 9.36% | 0.00% | 13,691,690 | 154,858 | 1.14% | 243,575,166 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.16% | 0.00% | 240,012 | 150,410 | 167.86% | 4,269,813 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.10% | 0.04% | 149,418 | 149,418 | 100.00% | 2,658,146 | Jun 30, 2024 |
As of Jun 30 2024, TG Therapeutics's largest institutional buyer is DEEP TRACK CAPITAL, LP. The company purchased 2.87M stocks of TGTX, valued at $51.06M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 0.04% | 0.00% | 65,071 | -3,088,522 | -97.94% | 1,157,613 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.00% | 0.01% | 1,457,908 | -2,026,138 | -58.15% | 25,936,183 | Jun 30, 2024 |
| STATE STREET CORP | 4.58% | 0.01% | 6,696,143 | -1,100,436 | -14.11% | 119,124,384,000 | Jun 30, 2024 |
| VESTAL POINT CAPITAL, LP | - | - | - | -1,050,000 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.21% | 0.01% | 309,371 | -531,229 | -63.20% | 5,503,710 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.12% | 0.01% | 180,338 | -344,523 | -65.64% | 3,208,213 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.34% | 2.79% | 500,000 | -325,000 | -39.39% | 8,895,000 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| DUQUESNE FAMILY OFFICE LLC | - | - | - | -280,000 | -100.00% | - | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.96% | 1.88% | 1,400,000 | -225,000 | -13.85% | 24,906,000 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.18% | 0.03% | 270,284 | -220,814 | -44.96% | 4,808,350 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.23% | 0.02% | 336,964 | -209,555 | -38.34% | 5,994,590 | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -191,900 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 0.83% | 0.00% | 1,215,577 | -180,975 | -12.96% | 21,625,111 | Jun 30, 2024 |
| GTS SECURITIES LLC | 0.05% | 0.00% | 74,100 | -141,600 | -65.65% | 1,318,239 | Jun 30, 2024 |
| SOFINNOVA INVESTMENTS, INC. | 1.27% | 1.72% | 1,861,277 | -123,685 | -6.23% | 33,112,118 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.42% | 0.00% | 2,081,888 | -119,562 | -5.43% | 37,036,788 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -107,363 | -100.00% | - | Jun 30, 2024 |
| INVESCO LTD. | 0.32% | 0.00% | 470,316 | -93,323 | -16.56% | 8,366,922 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.10% | 0.01% | 144,648 | -87,699 | -37.74% | 2,573,288 | Jun 30, 2024 |
As of Jun 30 2024, TG Therapeutics's biggest institutional seller is WELLINGTON MANAGEMENT GROUP LLP. The company sold -3.09M shares of TGTX, valued at $1.16M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 1.96% | 1.52% | 2,870,131 | 2,870,131 | 100.00% | 51,059,630 | Jun 30, 2024 |
| NORGES BANK | 0.41% | 0.00% | 597,300 | 597,300 | 100.00% | 10,625,967 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.40% | 0.03% | 585,873 | 585,873 | 100.00% | 10,422,676 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.33% | 0.02% | 488,943 | 488,943 | 100.00% | 8,698,296 | Jun 30, 2024 |
| JUMP FINANCIAL, LLC | 0.21% | 0.11% | 309,004 | 309,004 | 100.00% | 5,497,181 | Jun 30, 2024 |
| POINT72 EUROPE (LONDON) LLP | 0.11% | 0.24% | 160,769 | 160,769 | 100.00% | 2,860,077 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.10% | 0.01% | 147,100 | 147,100 | 100.00% | 2,616,909 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 0.09% | 0.05% | 133,200 | 133,200 | 100.00% | 2,369,628 | Jun 30, 2024 |
| STATE OF NEW JERSEY COMMON PENSION FUND D | 0.08% | 0.01% | 113,683 | 113,683 | 100.00% | 2,022,421 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.07% | 0.00% | 100,000 | 100,000 | 100.00% | 1,779,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.06% | 0.00% | 82,647 | 82,647 | 100.00% | 1,472,320 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 75,112 | 75,112 | 100.00% | 1,336,242 | Jun 30, 2024 |
| GILDER GAGNON HOWE & CO LLC | 0.04% | 0.01% | 60,673 | 60,673 | 100.00% | 1,079,373 | Jun 30, 2024 |
| PEARL RIVER CAPITAL, LLC | 0.04% | 0.15% | 54,857 | 54,857 | 100.00% | 975,906 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.04% | 0.01% | 53,190 | 53,190 | 100.00% | 946,250 | Jun 30, 2024 |
| BARCLAYS PLC | 0.03% | 0.00% | 49,400 | 49,400 | 100.00% | 879,000 | Jun 30, 2024 |
| EMPOWERED FUNDS, LLC | 0.03% | 0.01% | 45,045 | 45,045 | 100.00% | 801,351 | Jun 30, 2024 |
| BURNEY CO/ | 0.03% | 0.03% | 44,998 | 44,998 | 100.00% | 800,514 | Jun 30, 2024 |
| DARK FOREST CAPITAL MANAGEMENT LP | 0.03% | 0.13% | 41,252 | 41,252 | 100.00% | 733,873 | Jun 30, 2024 |
| QUANTITATIVE INVESTMENT MANAGEMENT, LLC | 0.03% | 0.08% | 39,987 | 39,987 | 100.00% | 711,000 | Jun 30, 2024 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 0.03% | 0.16% | 39,357 | 39,357 | 100.00% | 700,161 | Jun 30, 2024 |
| ADVANTAGE ALPHA CAPITAL PARTNERS LP | 0.02% | 0.13% | 34,030 | 34,030 | 100.00% | 605,394 | Jun 30, 2024 |
| STRATEGIC FINANCIAL CONCEPTS, LLC | 0.02% | 0.00% | 29,776 | 29,776 | 100.00% | 1,550,000 | Jun 30, 2024 |
| PENSERRA CAPITAL MANAGEMENT LLC | 0.02% | 0.01% | 24,933 | 24,933 | 100.00% | 444,000 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.02% | 0.08% | 24,662 | 24,662 | 100.00% | 438,737 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.02% | 0.03% | 24,452 | 24,452 | 100.00% | 435,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.02% | 0.03% | 22,176 | 22,176 | 100.00% | 394,511 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.01% | 0.20% | 20,420 | 20,420 | 100.00% | 363,271 | Jun 30, 2024 |
| MYDA ADVISORS LLC | 0.01% | 0.08% | 20,000 | 20,000 | 100.00% | 355,800 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.01% | 0.00% | 10,000 | 10,000 | 100.00% | 177,900 | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | 0.00% | 0.01% | 6,980 | 6,980 | 100.00% | 124,174 | Jun 30, 2024 |
| OPTIVER HOLDING B.V. | 0.00% | - | 2,495 | 2,495 | 100.00% | 44,386 | Jun 30, 2024 |
| ASHTON THOMAS PRIVATE WEALTH, LLC | 0.00% | 0.00% | 1,986 | 1,986 | 100.00% | 35,331 | Jun 30, 2024 |
| HAREL INSURANCE INVESTMENTS & FINANCIAL SERVICES LTD. | 0.00% | 0.00% | 820 | 820 | 100.00% | 15,000 | Jun 30, 2024 |
| RONALD BLUE TRUST, INC. | 0.00% | 0.00% | 667 | 667 | 100.00% | 10,145 | Jun 30, 2024 |
| COPPELL ADVISORY SOLUTIONS LLC | 0.00% | 0.00% | 632 | 632 | 100.00% | 10,649 | Jun 30, 2024 |
| JNBA FINANCIAL ADVISORS | 0.00% | 0.00% | 300 | 300 | 100.00% | 5,337 | Jun 30, 2024 |
| HARBOUR INVESTMENTS, INC. | 0.00% | 0.00% | 149 | 149 | 100.00% | 2,651 | Jun 30, 2024 |
| PACIFIC CAPITAL WEALTH ADVISORS, INC | 0.00% | 0.00% | 100 | 100 | 100.00% | 1,779 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | - | - | 50 | 50 | 100.00% | 890,000 | Jun 30, 2024 |
| ORG PARTNERS LLC | - | 0.00% | 50 | 50 | 100.00% | 907,000 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 41 | 41 | 100.00% | 730 | Jun 30, 2024 |
TG Therapeutics's largest new institutional shareholder by number of shares is DEEP TRACK CAPITAL, LP, purchased 2.87M shares, valued at $51.06M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VESTAL POINT CAPITAL, LP | - | - | - | -1,050,000 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | - | - | - | -300,000 | -100.00% | - | Jun 30, 2024 |
| DUQUESNE FAMILY OFFICE LLC | - | - | - | -280,000 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -191,900 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -107,363 | -100.00% | - | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | - | - | - | -87,064 | -100.00% | - | Jun 30, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | - | - | - | -74,538 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -68,341 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -60,000 | -100.00% | - | Jun 30, 2024 |
| ENTROPY TECHNOLOGIES, LP | - | - | - | -53,969 | -100.00% | - | Jun 30, 2024 |
| FOX RUN MANAGEMENT, L.L.C. | - | - | - | -50,724 | -100.00% | - | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | - | - | - | -48,675 | -100.00% | - | Jun 30, 2024 |
| JUPITER ASSET MANAGEMENT LTD | - | - | - | -46,577 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -44,279 | -100.00% | - | Jun 30, 2024 |
| VALEO FINANCIAL ADVISORS, LLC | - | - | - | -43,344 | -100.00% | - | Jun 30, 2024 |
| NOMURA HOLDINGS INC | - | - | - | -42,520 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -39,627 | -100.00% | - | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | - | - | - | -38,490 | -100.00% | - | Jun 30, 2024 |
| POLAR ASSET MANAGEMENT PARTNERS INC. | - | - | - | -33,200 | -100.00% | - | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -23,000 | -100.00% | - | Jun 30, 2024 |
| PREVAIL INNOVATIVE WEALTH ADVISORS, LLC | - | - | - | -21,500 | -100.00% | - | Jun 30, 2024 |
| POINT72 (DIFC) LTD | - | - | - | -15,771 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -11,017 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -7,592 | -100.00% | - | Jun 30, 2024 |
| PRIVATE TRUST CO NA | - | - | - | -1,410 | -100.00% | - | Jun 30, 2024 |
| NEW COVENANT TRUST COMPANY, N.A. | - | - | - | -556 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -269 | -100.00% | - | Jun 30, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | - | - | - | -261 | -100.00% | - | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | - | - | - | -250 | -100.00% | - | Jun 30, 2024 |
| IFP ADVISORS, INC | - | - | - | -64 | -100.00% | - | Jun 30, 2024 |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | - | - | - | -40 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -25 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -5 | -100.00% | - | Jun 30, 2024 |
| QUEST PARTNERS LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2024 |
TG Therapeutics's largest sold out institutional shareholder by shares sold is VESTAL POINT CAPITAL, LP, sold -1.05M shares, valued at -, as of undefined.
TG Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| HIGHLAND FUNDS II | 4.56% | 67,500 | - | - | Dec 31, 2023 |
| Manager Directed Portfolios | 1.99% | 325,688 | - | - | Jan 31, 2024 |
| HSBC FUNDS | 1.40% | 45,150 | - | - | Jan 31, 2024 |
| DSS AMERICAFIRST QUANTITATIVE FUNDS | 1.07% | 24,345 | 5,145 | 26.80% | Dec 29, 2023 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 1.07% | 990,531 | - | - | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.83% | 203,026 | - | - | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES VII | 0.37% | 3,180,200 | - | - | Jan 31, 2024 |
| HIGHLAND GLOBAL ALLOCATION FUND | 0.32% | 321,300 | - | - | Dec 31, 2023 |
| REYNOLDS FUNDS INC | 0.21% | 2,400 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.18% | 93,167 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.15% | 400,000 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.12% | 291,186 | - | - | Jan 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.11% | 91,345 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.10% | 323,101 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.09% | 2,038 | -279 | -12.04% | Dec 31, 2023 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.09% | 31,927 | - | - | Mar 31, 2024 |
| NEW ECONOMY FUND | 0.09% | 403,824 | - | - | Feb 29, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.09% | 41,924 | - | - | Mar 31, 2024 |
| ALGER FUNDS | 0.08% | 75,303 | - | - | Jan 31, 2024 |
| Voya EQUITY TRUST | 0.08% | 113,020 | - | - | Feb 29, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.07% | 220,929 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.07% | 342,736 | - | - | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.07% | 23,739 | - | - | Mar 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.07% | 63,216 | - | - | Feb 29, 2024 |
| ALLSPRING VARIABLE TRUST | 0.06% | 39,800 | - | - | Mar 31, 2024 |
| PUTNAM GLOBAL HEALTH CARE FUND | 0.06% | 97,400 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 10,986 | 10,986 | - | Mar 28, 2024 |
| VANGUARD SPECIALIZED FUNDS | 0.06% | 3,066,304 | - | - | Jan 31, 2024 |
| ACAP Strategic Fund | 0.05% | 755,903 | - | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.04% | 161,509 | 124,576 | 337.30% | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.04% | 244,820 | -6,127 | -2.44% | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.04% | 18,910 | - | - | Mar 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.03% | 2,450,200 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 20,484 | -449 | -2.14% | Mar 31, 2024 |
| SARATOGA ADVANTAGE TRUST | 0.03% | 2,077 | - | - | Feb 29, 2024 |
| GROWTH FUND OF AMERICA | 0.03% | 730,935 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.03% | 11,707,689 | -2,163,641 | -15.60% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.02% | 1,440,120 | 281,600 | 24.31% | Feb 29, 2024 |
| AIM FUNDS GROUP (INVESCO FUNDS GROUP) | 0.02% | 111,371 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.02% | 78,437 | - | - | Mar 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.02% | 639,968 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 65,526 | 1,054 | 1.63% | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,818,107 | - | - | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 557,664 | - | - | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.02% | 3,788 | - | - | Mar 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.02% | 870,000 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENT TRUST | 0.02% | 48,256 | - | - | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.02% | 368,882 | - | - | Mar 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.02% | 73,329 | - | - | Jan 31, 2024 |
| HUSSMAN INVESTMENT TRUST | 0.01% | 52,500 | - | - | Dec 31, 2023 |
| ALPS ETF Trust | 0.01% | 171,759 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.01% | 51,044 | -17,376 | -25.40% | Dec 31, 2023 |
| JNL VARIABLE FUND LLC | 0.01% | 65,252 | 13,988 | 27.29% | Mar 31, 2020 |
| VANGUARD EXPLORER FUND | 0.01% | 142,144 | 84,872 | 148.19% | Jan 31, 2024 |
| NEXPOINT DIVERSIFIED REAL ESTATE TRUST | 0.01% | 110,000 | - | - | Jun 30, 2022 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.01% | 89,800 | - | - | Mar 31, 2024 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.01% | 1,000 | - | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.01% | 220,000 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.01% | 48,600 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 414,146 | 2,335 | 0.57% | Jan 31, 2024 |
| IndexIQ ETF Trust | 0.01% | 21,521 | - | - | Jan 31, 2024 |
| CARILLON SERIES TRUST | 0.01% | 491,296 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 67,826 | - | - | Mar 28, 2024 |
| Bernstein Fund Inc | 0.01% | 60,950 | - | - | Mar 31, 2024 |
| VICTORY PORTFOLIOS | 0.01% | 206,680 | - | - | Mar 31, 2024 |
| NEUBERGER BERMAN EQUITY FUNDS | 0.01% | 64,480 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,335,204 | 38,011 | 2.93% | Feb 29, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.01% | 14,412 | - | - | Mar 31, 2024 |
| VALUED ADVISERS TRUST | 0.01% | 5,963 | -5,607 | -48.46% | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.01% | 7,082 | -2,429 | -25.54% | Dec 31, 2023 |
| SunAmerica Specialty Series | 0.01% | 3,033 | -247 | -7.53% | Apr 30, 2021 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.01% | 478,107 | 242,849 | 103.23% | Jan 31, 2024 |
| FORUM FUNDS | 0.01% | 13,045 | - | - | Jan 31, 2024 |
| AMG Funds I | 0.01% | 10,971 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.01% | 14,355 | - | - | Mar 31, 2024 |
| FIDELITY CONTRAFUND | 0.01% | 338,651 | - | - | Mar 31, 2024 |
| John Hancock Exchange-Traded Fund Trust | 0.01% | 31,383 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.01% | 13,968 | 3,875 | 38.39% | Mar 31, 2024 |
| Gabelli Healthcare & WellnessRx Trust | 0.00% | 585 | - | - | Dec 29, 2023 |
| AMG FUNDS III | 0.00% | 24,918 | - | - | Mar 28, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 17,958 | 163 | 0.92% | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.00% | 44,338 | - | - | Mar 31, 2024 |
| FundVantage Trust | 0.00% | 60,164 | - | - | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 690,261 | - | - | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 548,349 | -124,499 | -18.50% | Jan 31, 2024 |
| ETFis Series Trust I | 0.00% | 4,559 | 925 | 25.45% | Jan 31, 2024 |
| Guardian Variable Products Trust | 0.00% | 50,000 | - | - | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 28,755 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 85,919 | -6,595 | -7.13% | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 110,084 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 28,822 | -4,358 | -13.13% | Mar 31, 2024 |
| AMG Funds IV | 0.00% | 7,298 | - | - | Jan 31, 2024 |
| AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST) | 0.00% | 531,132 | - | - | Feb 29, 2024 |
| VANGUARD WORLD FUND | 0.00% | 515,835 | 7,964 | 1.57% | Feb 29, 2024 |
| SSGA FUNDS | 0.00% | 906 | - | - | Feb 29, 2024 |
| AdvisorShares Trust | 0.00% | 6,945 | - | - | Mar 28, 2024 |
| DEUTSCHE DWS VARIABLE SERIES II | 0.00% | 4,142 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 45,536 | -9,452 | -17.19% | Mar 31, 2024 |
| Global X Funds | 0.00% | 61,735 | 3,709 | 6.39% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 16,730 | -1,376 | -7.60% | Mar 31, 2024 |
TG Therapeutics's largest mutual fund holder by % of total assets is "HIGHLAND FUNDS II", owning 67.50K shares, compromising 4.56% of its total assets.
TG Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 95 | -63.60% |
| 31 Mar, 24 | 261 | 0.77% |
| 31 Dec, 23 | 259 | 0.39% |
| 30 Sep, 23 | 258 | -5.49% |
| 30 Jun, 23 | 273 | 19.21% |
| 31 Mar, 23 | 229 | 3.62% |
| 31 Dec, 22 | 221 | 11.62% |
| 30 Sep, 22 | 198 | 3.66% |
| 30 Jun, 22 | 191 | -5.45% |
| 31 Mar, 22 | 202 | -7.34% |
| 31 Dec, 21 | 218 | -13.49% |
| 30 Sep, 21 | 252 | -2.70% |
| 30 Jun, 21 | 259 | 1.97% |
| 31 Mar, 21 | 254 | -6.62% |
| 31 Dec, 20 | 272 | 36.00% |
| 30 Sep, 20 | 200 | 3.09% |
| 30 Jun, 20 | 194 | 21.25% |
| 31 Mar, 20 | 160 | 3.23% |
| 31 Dec, 19 | 155 | 23.02% |
| 30 Sep, 19 | 126 | -4.55% |
| 30 Jun, 19 | 132 | 3.13% |
| 31 Mar, 19 | 128 | 6.67% |
| 31 Dec, 18 | 120 | -18.92% |
| 30 Sep, 18 | 148 | 3.50% |
| 30 Jun, 18 | 143 | 7.52% |
| 31 Mar, 18 | 133 | 18.75% |
| 31 Dec, 17 | 112 | 2.75% |
| 30 Sep, 17 | 109 | -3.54% |
| 30 Jun, 17 | 113 | 3.67% |
| 31 Mar, 17 | 109 | 21.11% |
| 31 Dec, 16 | 90 | 15.38% |
| 30 Sep, 16 | 78 | -15.22% |
| 30 Jun, 16 | 92 | 8.24% |
| 31 Mar, 16 | 85 | -6.59% |
| 31 Dec, 15 | 91 | 8.33% |
| 30 Sep, 15 | 84 | -10.64% |
| 30 Jun, 15 | 94 | 11.90% |
| 31 Mar, 15 | 84 | 5.00% |
| 31 Dec, 14 | 80 | 11.11% |
| 30 Sep, 14 | 72 | 2.86% |
| 30 Jun, 14 | 70 | 27.27% |
| 31 Mar, 14 | 55 | 25.00% |
| 31 Dec, 13 | 44 | -2.22% |
| 30 Sep, 13 | 45 | 36.36% |
| 30 Jun, 13 | 33 | - |
As of 30 Jun 24, 95 institutions are holding TG Therapeutics's shares, representing a decrease of -63.60% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 11,036,649 | -87.66% |
| 31 Mar, 24 | 89,431,150 | -0.59% |
| 31 Dec, 23 | 89,964,121 | 0.71% |
| 30 Sep, 23 | 89,331,949 | 2.61% |
| 30 Jun, 23 | 87,062,480 | -7.84% |
| 31 Mar, 23 | 94,471,783 | 1.64% |
| 31 Dec, 22 | 92,951,637 | -7.08% |
| 30 Sep, 22 | 100,038,699 | -5.96% |
| 30 Jun, 22 | 106,379,013 | 5.31% |
| 31 Mar, 22 | 101,017,373 | 0.74% |
| 31 Dec, 21 | 100,273,853 | 3.96% |
| 30 Sep, 21 | 96,451,946 | 0.21% |
| 30 Jun, 21 | 96,245,673 | -2.60% |
| 31 Mar, 21 | 98,811,007 | -1.18% |
| 31 Dec, 20 | 99,992,911 | 14.03% |
| 30 Sep, 20 | 87,692,638 | 4.46% |
| 30 Jun, 20 | 83,949,865 | 29.55% |
| 31 Mar, 20 | 64,801,289 | 11.35% |
| 31 Dec, 19 | 58,196,054 | 20.18% |
| 30 Sep, 19 | 48,425,224 | -3.62% |
| 30 Jun, 19 | 50,242,590 | 4.40% |
| 31 Mar, 19 | 48,123,423 | -1.59% |
| 31 Dec, 18 | 48,898,717 | 2.51% |
| 30 Sep, 18 | 47,700,341 | 17.20% |
| 30 Jun, 18 | 40,700,010 | 5.45% |
| 31 Mar, 18 | 38,596,704 | 7.90% |
| 31 Dec, 17 | 35,771,719 | 0.44% |
| 30 Sep, 17 | 35,616,765 | 3.71% |
| 30 Jun, 17 | 34,344,045 | 11.53% |
| 31 Mar, 17 | 30,793,741 | 41.95% |
| 31 Dec, 16 | 21,693,613 | -19.81% |
| 30 Sep, 16 | 27,051,736 | -7.16% |
| 30 Jun, 16 | 29,139,027 | -1.51% |
| 31 Mar, 16 | 29,585,292 | 10.05% |
| 31 Dec, 15 | 26,884,079 | -4.10% |
| 30 Sep, 15 | 28,032,710 | 17.44% |
| 30 Jun, 15 | 23,870,683 | 11.19% |
| 31 Mar, 15 | 21,469,278 | 14.78% |
| 31 Dec, 14 | 18,705,515 | 20.84% |
| 30 Sep, 14 | 15,479,690 | 19.44% |
| 30 Jun, 14 | 12,960,586 | 11.34% |
| 31 Mar, 14 | 11,641,065 | 63.91% |
| 31 Dec, 13 | 7,102,212 | 6.99% |
| 30 Sep, 13 | 6,637,989 | 265.52% |
| 30 Jun, 13 | 1,816,062 | - |
TG Therapeutics (TGTX) has 11.04M shares outstanding as of 30 Jun 24, down -87.66% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 7.55% | 0.19% |
| 31 Mar, 24 | 62.50% | 1.58% |
| 31 Dec, 23 | 62.97% | 1.58% |
| 30 Sep, 23 | 63.13% | 1.64% |
| 30 Jun, 23 | 62.05% | 1.37% |
| 31 Mar, 23 | 67.33% | 1.43% |
| 31 Dec, 22 | 68.64% | 1.26% |
| 30 Sep, 22 | 73.92% | 1.19% |
| 30 Jun, 22 | 78.93% | 1.40% |
| 31 Mar, 22 | 75.16% | 1.31% |
| 31 Dec, 21 | 75.84% | 1.43% |
| 30 Sep, 21 | 72.87% | 1.37% |
| 30 Jun, 21 | 72.87% | 1.30% |
| 31 Mar, 21 | 74.91% | 1.00% |
| 31 Dec, 20 | 86.70% | 1.60% |
| 30 Sep, 20 | 73.58% | 1.32% |
| 30 Jun, 20 | 74.72% | 1.98% |
| 31 Mar, 20 | 61.45% | 1.66% |
| 31 Dec, 19 | 60.84% | 2.09% |
| 30 Sep, 19 | 54.01% | 1.61% |
| 30 Jun, 19 | 57.88% | 1.65% |
| 31 Mar, 19 | 59.28% | 1.63% |
| 31 Dec, 18 | 60.24% | 1.62% |
| 30 Sep, 18 | 60.98% | 1.92% |
| 30 Jun, 18 | 56.33% | 1.89% |
| 31 Mar, 18 | 54.64% | 1.65% |
| 31 Dec, 17 | 57.63% | 1.92% |
| 30 Sep, 17 | 54.73% | 1.86% |
| 30 Jun, 17 | 54.27% | 1.62% |
| 31 Mar, 17 | 57.93% | 2.96% |
| 31 Dec, 16 | 44.24% | 1.46% |
| 30 Sep, 16 | 54.98% | 1.54% |
| 30 Jun, 16 | 59.75% | 1.63% |
| 31 Mar, 16 | 60.49% | 1.94% |
| 31 Dec, 15 | 55.86% | 1.63% |
| 30 Sep, 15 | 58.47% | 2.11% |
| 30 Jun, 15 | 52.67% | 1.64% |
| 31 Mar, 15 | 56.72% | 1.88% |
| 31 Dec, 14 | 54.90% | 2.68% |
| 30 Sep, 14 | 45.28% | 2.93% |
| 30 Jun, 14 | 39.29% | 2.63% |
| 31 Mar, 14 | 38.69% | 4.95% |
| 31 Dec, 13 | 27.95% | 4.86% |
| 30 Sep, 13 | 23.98% | 36.75% |
| 30 Jun, 13 | 8.08% | - |
As of 30 Jun 24, TG Therapeutics is held by 7.55% institutional shareholders, representing a 0.19% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 51 | -59.20% |
| 31 Mar, 24 | 125 | 8.70% |
| 31 Dec, 23 | 115 | -16.67% |
| 30 Sep, 23 | 138 | -0.72% |
| 30 Jun, 23 | 139 | 18.80% |
| 31 Mar, 23 | 117 | 7.34% |
| 31 Dec, 22 | 109 | 15.96% |
| 30 Sep, 22 | 94 | -3.09% |
| 30 Jun, 22 | 97 | -5.83% |
| 31 Mar, 22 | 103 | 3.00% |
| 31 Dec, 21 | 100 | -8.26% |
| 30 Sep, 21 | 109 | -16.79% |
| 30 Jun, 21 | 131 | 2.34% |
| 31 Mar, 21 | 128 | -23.35% |
| 31 Dec, 20 | 167 | 56.07% |
| 30 Sep, 20 | 107 | -13.71% |
| 30 Jun, 20 | 124 | 58.97% |
| 31 Mar, 20 | 78 | -4.88% |
| 31 Dec, 19 | 82 | 38.98% |
| 30 Sep, 19 | 59 | -10.61% |
| 30 Jun, 19 | 66 | 13.79% |
| 31 Mar, 19 | 58 | 9.43% |
| 31 Dec, 18 | 53 | -18.46% |
| 30 Sep, 18 | 65 | -16.67% |
| 30 Jun, 18 | 78 | 11.43% |
| 31 Mar, 18 | 70 | 16.67% |
| 31 Dec, 17 | 60 | 42.86% |
| 30 Sep, 17 | 42 | -30.00% |
| 30 Jun, 17 | 60 | -16.67% |
| 31 Mar, 17 | 72 | 26.32% |
| 31 Dec, 16 | 57 | 111.11% |
| 30 Sep, 16 | 27 | -43.75% |
| 30 Jun, 16 | 48 | 14.29% |
| 31 Mar, 16 | 42 | -17.65% |
| 31 Dec, 15 | 51 | 15.91% |
| 30 Sep, 15 | 44 | -32.31% |
| 30 Jun, 15 | 65 | 18.18% |
| 31 Mar, 15 | 55 | -1.79% |
| 31 Dec, 14 | 56 | 40.00% |
| 30 Sep, 14 | 40 | -6.98% |
| 30 Jun, 14 | 43 | 30.30% |
| 31 Mar, 14 | 33 | 32.00% |
| 31 Dec, 13 | 25 | -28.57% |
| 30 Sep, 13 | 35 | 6.06% |
| 30 Jun, 13 | 33 | - |
51 institutional shareholders have increased their position in TGTX stock as of 30 Jun 24 compared to 125 in the previous quarter (a -59.20% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 18 | -76.00% |
| 31 Mar, 24 | 75 | 2.74% |
| 31 Dec, 23 | 73 | 25.86% |
| 30 Sep, 23 | 58 | -18.31% |
| 30 Jun, 23 | 71 | 10.94% |
| 31 Mar, 23 | 64 | 12.28% |
| 31 Dec, 22 | 57 | -1.72% |
| 30 Sep, 22 | 58 | 13.73% |
| 30 Jun, 22 | 51 | - |
| 31 Mar, 22 | 51 | -13.56% |
| 31 Dec, 21 | 59 | -25.32% |
| 30 Sep, 21 | 79 | 8.22% |
| 30 Jun, 21 | 73 | -6.41% |
| 31 Mar, 21 | 78 | 34.48% |
| 31 Dec, 20 | 58 | 11.54% |
| 30 Sep, 20 | 52 | 48.57% |
| 30 Jun, 20 | 35 | -23.91% |
| 31 Mar, 20 | 46 | 39.39% |
| 31 Dec, 19 | 33 | 6.45% |
| 30 Sep, 19 | 31 | -3.13% |
| 30 Jun, 19 | 32 | 10.34% |
| 31 Mar, 19 | 29 | -3.33% |
| 31 Dec, 18 | 30 | -21.05% |
| 30 Sep, 18 | 38 | 8.57% |
| 30 Jun, 18 | 35 | 2.94% |
| 31 Mar, 18 | 34 | 100.00% |
| 31 Dec, 17 | 17 | -34.62% |
| 30 Sep, 17 | 26 | -3.70% |
| 30 Jun, 17 | 27 | 50.00% |
| 31 Mar, 17 | 18 | 12.50% |
| 31 Dec, 16 | 16 | -38.46% |
| 30 Sep, 16 | 26 | 23.81% |
| 30 Jun, 16 | 21 | - |
| 31 Mar, 16 | 21 | - |
| 31 Dec, 15 | 21 | -16.00% |
| 30 Sep, 15 | 25 | 19.05% |
| 30 Jun, 15 | 21 | 16.67% |
| 31 Mar, 15 | 18 | 50.00% |
| 31 Dec, 14 | 12 | -29.41% |
| 30 Sep, 14 | 17 | - |
| 30 Jun, 14 | 17 | 54.55% |
| 31 Mar, 14 | 11 | - |
| 31 Dec, 13 | 11 | 83.33% |
| 30 Sep, 13 | 6 | - |
| 30 Jun, 13 | - | - |
18 institutional shareholders have reduced their position in TGTX stock as of 30 Jun 24 compared to 75 in the previous quarter (a -76.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 95 | -63.60% | 11,036,649 | -87.66% | 7.55% | 0.19% | 51 | -59.20% | 18 | -76.00% |
| 31 Mar, 24 | 261 | 0.77% | 89,431,150 | -0.59% | 62.50% | 1.58% | 125 | 8.70% | 75 | 2.74% |
| 31 Dec, 23 | 259 | 0.39% | 89,964,121 | 0.71% | 62.97% | 1.58% | 115 | -16.67% | 73 | 25.86% |
| 30 Sep, 23 | 258 | -5.49% | 89,331,949 | 2.61% | 63.13% | 1.64% | 138 | -0.72% | 58 | -18.31% |
| 30 Jun, 23 | 273 | 19.21% | 87,062,480 | -7.84% | 62.05% | 1.37% | 139 | 18.80% | 71 | 10.94% |
| 31 Mar, 23 | 229 | 3.62% | 94,471,783 | 1.64% | 67.33% | 1.43% | 117 | 7.34% | 64 | 12.28% |
| 31 Dec, 22 | 221 | 11.62% | 92,951,637 | -7.08% | 68.64% | 1.26% | 109 | 15.96% | 57 | -1.72% |
| 30 Sep, 22 | 198 | 3.66% | 100,038,699 | -5.96% | 73.92% | 1.19% | 94 | -3.09% | 58 | 13.73% |
| 30 Jun, 22 | 191 | -5.45% | 106,379,013 | 5.31% | 78.93% | 1.40% | 97 | -5.83% | 51 | - |
| 31 Mar, 22 | 202 | -7.34% | 101,017,373 | 0.74% | 75.16% | 1.31% | 103 | 3.00% | 51 | -13.56% |
| 31 Dec, 21 | 218 | -13.49% | 100,273,853 | 3.96% | 75.84% | 1.43% | 100 | -8.26% | 59 | -25.32% |
| 30 Sep, 21 | 252 | -2.70% | 96,451,946 | 0.21% | 72.87% | 1.37% | 109 | -16.79% | 79 | 8.22% |
| 30 Jun, 21 | 259 | 1.97% | 96,245,673 | -2.60% | 72.87% | 1.30% | 131 | 2.34% | 73 | -6.41% |
| 31 Mar, 21 | 254 | -6.62% | 98,811,007 | -1.18% | 74.91% | 1.00% | 128 | -23.35% | 78 | 34.48% |
| 31 Dec, 20 | 272 | 36.00% | 99,992,911 | 14.03% | 86.70% | 1.60% | 167 | 56.07% | 58 | 11.54% |
| 30 Sep, 20 | 200 | 3.09% | 87,692,638 | 4.46% | 73.58% | 1.32% | 107 | -13.71% | 52 | 48.57% |
| 30 Jun, 20 | 194 | 21.25% | 83,949,865 | 29.55% | 74.72% | 1.98% | 124 | 58.97% | 35 | -23.91% |
| 31 Mar, 20 | 160 | 3.23% | 64,801,289 | 11.35% | 61.45% | 1.66% | 78 | -4.88% | 46 | 39.39% |
| 31 Dec, 19 | 155 | 23.02% | 58,196,054 | 20.18% | 60.84% | 2.09% | 82 | 38.98% | 33 | 6.45% |
| 30 Sep, 19 | 126 | -4.55% | 48,425,224 | -3.62% | 54.01% | 1.61% | 59 | -10.61% | 31 | -3.13% |
| 30 Jun, 19 | 132 | 3.13% | 50,242,590 | 4.40% | 57.88% | 1.65% | 66 | 13.79% | 32 | 10.34% |
| 31 Mar, 19 | 128 | 6.67% | 48,123,423 | -1.59% | 59.28% | 1.63% | 58 | 9.43% | 29 | -3.33% |
| 31 Dec, 18 | 120 | -18.92% | 48,898,717 | 2.51% | 60.24% | 1.62% | 53 | -18.46% | 30 | -21.05% |
| 30 Sep, 18 | 148 | 3.50% | 47,700,341 | 17.20% | 60.98% | 1.92% | 65 | -16.67% | 38 | 8.57% |
| 30 Jun, 18 | 143 | 7.52% | 40,700,010 | 5.45% | 56.33% | 1.89% | 78 | 11.43% | 35 | 2.94% |
| 31 Mar, 18 | 133 | 18.75% | 38,596,704 | 7.90% | 54.64% | 1.65% | 70 | 16.67% | 34 | 100.00% |
| 31 Dec, 17 | 112 | 2.75% | 35,771,719 | 0.44% | 57.63% | 1.92% | 60 | 42.86% | 17 | -34.62% |
| 30 Sep, 17 | 109 | -3.54% | 35,616,765 | 3.71% | 54.73% | 1.86% | 42 | -30.00% | 26 | -3.70% |
| 30 Jun, 17 | 113 | 3.67% | 34,344,045 | 11.53% | 54.27% | 1.62% | 60 | -16.67% | 27 | 50.00% |
| 31 Mar, 17 | 109 | 21.11% | 30,793,741 | 41.95% | 57.93% | 2.96% | 72 | 26.32% | 18 | 12.50% |
| 31 Dec, 16 | 90 | 15.38% | 21,693,613 | -19.81% | 44.24% | 1.46% | 57 | 111.11% | 16 | -38.46% |
| 30 Sep, 16 | 78 | -15.22% | 27,051,736 | -7.16% | 54.98% | 1.54% | 27 | -43.75% | 26 | 23.81% |
| 30 Jun, 16 | 92 | 8.24% | 29,139,027 | -1.51% | 59.75% | 1.63% | 48 | 14.29% | 21 | - |
| 31 Mar, 16 | 85 | -6.59% | 29,585,292 | 10.05% | 60.49% | 1.94% | 42 | -17.65% | 21 | - |
| 31 Dec, 15 | 91 | 8.33% | 26,884,079 | -4.10% | 55.86% | 1.63% | 51 | 15.91% | 21 | -16.00% |
| 30 Sep, 15 | 84 | -10.64% | 28,032,710 | 17.44% | 58.47% | 2.11% | 44 | -32.31% | 25 | 19.05% |
| 30 Jun, 15 | 94 | 11.90% | 23,870,683 | 11.19% | 52.67% | 1.64% | 65 | 18.18% | 21 | 16.67% |
| 31 Mar, 15 | 84 | 5.00% | 21,469,278 | 14.78% | 56.72% | 1.88% | 55 | -1.79% | 18 | 50.00% |
| 31 Dec, 14 | 80 | 11.11% | 18,705,515 | 20.84% | 54.90% | 2.68% | 56 | 40.00% | 12 | -29.41% |
| 30 Sep, 14 | 72 | 2.86% | 15,479,690 | 19.44% | 45.28% | 2.93% | 40 | -6.98% | 17 | - |
| 30 Jun, 14 | 70 | 27.27% | 12,960,586 | 11.34% | 39.29% | 2.63% | 43 | 30.30% | 17 | 54.55% |
| 31 Mar, 14 | 55 | 25.00% | 11,641,065 | 63.91% | 38.69% | 4.95% | 33 | 32.00% | 11 | - |
| 31 Dec, 13 | 44 | -2.22% | 7,102,212 | 6.99% | 27.95% | 4.86% | 25 | -28.57% | 11 | 83.33% |
| 30 Sep, 13 | 45 | 36.36% | 6,637,989 | 265.52% | 23.98% | 36.75% | 35 | 6.06% | 6 | - |
| 30 Jun, 13 | 33 | - | 1,816,062 | - | 8.08% | - | 33 | - | - | - |
TG Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of TG Therapeutics's stock was made by Lonial Sagar on Jun 20 2024, selling 16,348 shares at $16.87 per share (valued at $275.79K). The last insider buy of TGTX was made by WEISS MICHAEL S on Aug 14 2023, buying 100,000 shares at $10.13 per share (worth $1.01M).
TG Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 5 | 2 | 250.00% |
| Q1 2024 | 2 | 4 | 50.00% |
| Q3 2023 | 5 | 1 | 500.00% |
| Q2 2023 | - | 2 | - |
| Q1 2023 | 3 | 1 | 300.00% |
| Q3 2022 | 9 | - | - |
| Q1 2022 | - | 4 | - |
| Q4 2021 | 1 | 3 | 33.33% |
| Q2 2021 | 8 | - | - |
| Q4 2020 | 1 | 1 | 100.00% |
| Q3 2020 | 2 | 1 | 200.00% |
| Q2 2020 | 6 | 2 | 300.00% |
| Q3 2019 | 5 | 1 | 500.00% |
| Q2 2019 | 2 | - | - |
| Q1 2019 | - | 1 | - |
| Q4 2018 | 1 | - | - |
| Q3 2018 | - | 2 | - |
| Q2 2018 | 7 | 1 | 700.00% |
| Q1 2018 | - | 1 | - |
| Q4 2017 | 1 | - | - |
5 total buy trades, and 2 total sell trades (buy/sell ratio of 2.50%) were made by TG Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 2 | - |
| Q1 2024 | - | 4 | - |
| Q3 2023 | 1 | - | - |
| Q2 2023 | - | 2 | - |
| Q1 2023 | 1 | 1 | 100.00% |
| Q3 2022 | - | - | - |
| Q1 2022 | - | 4 | - |
| Q4 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q4 2020 | - | 1 | - |
| Q3 2020 | - | 1 | - |
| Q2 2020 | - | 1 | - |
| Q3 2019 | - | 1 | - |
| Q2 2019 | 1 | - | - |
| Q1 2019 | - | 1 | - |
| Q4 2018 | - | - | - |
| Q3 2018 | - | 2 | - |
| Q2 2018 | - | 1 | - |
| Q1 2018 | - | 1 | - |
| Q4 2017 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of TG Therapeutics's stocks.
TG Therapeutics Peer Ownership
TGTX Ownership FAQ
Who Owns TG Therapeutics?
TG Therapeutics is owned by institutional shareholders (7.55%), insiders (9.59%), and public (82.86%). The largest institutional shareholder of TG Therapeutics is VANGUARD GROUP INC (9.36% of total shares) and the top mutual fund owner is HIGHLAND FUNDS II (4.56% of total shares).
Who are the major institutional shareholders of TG Therapeutics?
TG Therapeutics's major institutional shareholders are VANGUARD GROUP INC, BLACKROCK INC., STATE STREET CORP, SOLEUS CAPITAL MANAGEMENT, L.P., and PICTET ASSET MANAGEMENT HOLDING SA. The top five shareholders own together 26.45% of the company's share outstanding.
How many TG Therapeutics shareholders are there?
As of Jun 2024, there are 95 institutional shareholders of TG Therapeutics.
What percentage of TG Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC owns 13.69M shares of TG Therapeutics, representing 9.36% of the company's total shares outstanding, valued at $243.58M (as of Jun 2024).
What percentage of TG Therapeutics is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 11.39M shares of TG Therapeutics (TGTX), compromising 7.79% of the company, valued at $202.6M.
What percentage of TG Therapeutics is owned by STATE STREET CORP?
STATE STREET CORP is the third largest holder of TG Therapeutics. The company owns 6.7M of the company's shares outstanding (worth $119.12B).